Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Enobia Pharma
company
About
Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
- 1001 - 5000
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15.55M
- Industries
- Biotechnology,Genetics,Health Care,Medical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15.55M
Enobia Pharma has raised a total of
$15.55M
in funding over 2 rounds. Their latest funding was raised on
Jan 18, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 18, 2005 | Series A | $15.55M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Enobia Pharma is funded by 1 investors.
T2C2 Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
T2C2 Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
